About Neurology Offices of South Florida
Clinical Trials at Neurology Offices of South Florida
During the past decade, Neurology Offices of South Florida conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 4 clinical trials were completed, i.e. on
average, 30.8% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 4 clinical trials were completed. i.e. 44.4%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Neurology Offices of South Florida" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Allergan" with 2 trials
sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Cassava Sciences, Inc."
with 2 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Neurology Offices of South Florida"
#1 collaborator was "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Neurology Offices of South Florida
According to Clinical.Site data, the most researched conditions in "Neurology Offices of South Florida" are
"Alzheimer Disease" (4 trials), "Migraine" (3 trials), "Agitation in Patients With Dementia of the Alzheimer's Type" (2 trials), "Episodic Migraine" (2 trials) and "Cervical Dystonia" (1 trials). Many other conditions were trialed in "Neurology Offices of South Florida" in a lesser frequency.
Clinical Trials Intervention Types at Neurology Offices of South Florida
Most popular intervention types in "Neurology Offices of South Florida" are "Drug" (13 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "AVP-786" (2 trials), "Atogepant" (2 trials), "Donanemab" (2 trials) and "BHV-3500 (zavegepant)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Neurology Offices of South Florida
The vast majority of trials in "Neurology Offices of South Florida" are
14 trials for "All" genders.
Clinical Trials Status at Neurology Offices of South Florida
Currently, there are NaN active trials in "Neurology Offices of South Florida".
undefined are not yet recruiting,
4 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Neurology Offices of South Florida,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Neurology Offices of South Florida, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 11 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".